Cladis Investment Advisory’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-42,700
| Closed | -$29.9K | – | 148 |
|
|
2025
Q1 | $29.9K | Hold |
42,700
| – | – | 0.02% | 136 |
|
|
2024
Q4 | $51.2K | Buy |
42,700
+3,000
| +8% | +$3.6K | 0.04% | 129 |
|
|
2024
Q3 | $67.9K | Hold |
39,700
| – | – | 0.05% | 133 |
|
|
2024
Q2 | $46.4K | Buy |
+39,700
| New | +$46.4K | 0.03% | 134 |
|
|
2024
Q1 | – | Sell |
-31,700
| Closed | -$124K | – | 140 |
|
|
2023
Q4 | $124K | Sell |
31,700
-4,450
| -12% | -$17.4K | 0.1% | 135 |
|
|
2023
Q3 | $208K | Sell |
36,150
-1,100
| -3% | -$6.33K | 0.18% | 119 |
|
|
2023
Q2 | $302K | Sell |
37,250
-10,000
| -21% | -$81K | 0.26% | 102 |
|
|
2023
Q1 | $331K | Buy |
47,250
+3,550
| +8% | +$24.9K | 0.3% | 95 |
|
|
2022
Q4 | $309K | Sell |
43,700
-10,350
| -19% | -$73.1K | 0.31% | 94 |
|
|
2022
Q3 | $822K | Sell |
54,050
-8,300
| -13% | -$126K | 0.89% | 36 |
|
|
2022
Q2 | $619K | Sell |
62,350
-3,190
| -5% | -$31.7K | 0.62% | 55 |
|
|
2022
Q1 | $944K | Buy |
65,540
+19,450
| +42% | +$280K | 0.76% | 40 |
|
|
2021
Q4 | $2.41M | Buy |
+46,090
| New | +$2.41M | 1.93% | 7 |
|